Covered recipient · General Payments record
ANDREW D COLLINS
Allopathic & Osteopathic Physicians Allergy & Immunology
General Payments · PY2018–2024
$4,368.33
- Reported across 40 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $880.00 | 1 |
| Food and Beverage | $435.62 | 9 |
| Education | $46.64 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $1,042.18 | 3 |
| Amgen Inc. | $144.27 | 1 |
| Acerta Pharma LLC | $69.45 | 2 |
| BioCryst US Sales Co., LLC | $24.84 | 1 |
| PFIZER INC. | $23.06 | 1 |
| Grifols USA, LLC | $22.31 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.41 | 1 |
| Kaleo, Inc. | $15.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $144.27 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111552752 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.81 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105868741 | CMS |
| AstraZeneca Pharmaceuticals LP | $46.64 | 11/04/2024 | Education | Undisputed | 01/23/2026 | 1104772812 | CMS |
| BioCryst US Sales Co., LLC | $24.84 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117475948 | CMS |
| GENZYME CORPORATION | $91.58 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139866196 | CMS |
| GENZYME CORPORATION | $880.00 | 03/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1139866278 | CMS |
| GENZYME CORPORATION | $70.60 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139866266 | CMS |
| Grifols USA, LLC | $22.31 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124726092 | CMS |
| kaleo, Inc. | $15.74 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126622724 | CMS |
| Novartis Pharmaceuticals Corporation | $20.41 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086763659 | CMS |
| PFIZER INC. | $23.06 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131998069 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.